New York State Common Retirement Fund’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-47,595
| Closed | -$1.83M | – | 3449 |
|
|
2023
Q2 | $1.83M | Sell |
47,595
-10,826
| -19% | -$278K | ﹤0.01% | 1529 |
|
|
2023
Q1 | $1.35M | Sell |
58,421
-11,695
| -17% | -$279K | ﹤0.01% | 1736 |
|
|
2022
Q4 | $1.84M | Buy |
70,116
+7,241
| +12% | +$160K | ﹤0.01% | 1688 |
|
|
2022
Q3 | $1.24M | Buy |
62,875
+862
| +1% | +$17.3K | ﹤0.01% | 1871 |
|
|
2022
Q2 | $1.08M | Buy |
62,013
+31,565
| +104% | +$495K | ﹤0.01% | 1975 |
|
|
2022
Q1 | $498K | Buy |
30,448
+4,606
| +18% | +$62.6K | ﹤0.01% | 2405 |
|
|
2021
Q4 | $421K | Buy |
25,842
+6,240
| +32% | +$88.8K | ﹤0.01% | 2524 |
|
|
2021
Q3 | $250K | Sell |
19,602
-7,480
| -28% | -$98.5K | ﹤0.01% | 2829 |
|
|
2021
Q2 | $382K | Buy |
27,082
+15,303
| +130% | +$245K | ﹤0.01% | 2743 |
|
|
2021
Q1 | $183K | Hold |
11,779
| – | – | ﹤0.01% | 2872 |
|
|
2020
Q4 | $187K | Sell |
11,779
-1
| -0% | -$15 | ﹤0.01% | 2784 |
|
|
2020
Q3 | $143K | Hold |
11,780
| – | – | ﹤0.01% | 2790 |
|
|
2020
Q2 | $136K | Hold |
11,780
| – | – | ﹤0.01% | 2822 |
|
|
2020
Q1 | $161K | Hold |
11,780
| – | – | ﹤0.01% | 2567 |
|
|
2019
Q4 | $70K | Hold |
11,780
| – | – | ﹤0.01% | 3079 |
|
|
2019
Q3 | $62K | Hold |
11,780
| – | – | ﹤0.01% | 3137 |
|
|
2019
Q2 | $91K | Hold |
11,780
| – | – | ﹤0.01% | 3142 |
|
|
2019
Q1 | $234K | Hold |
11,780
| – | – | ﹤0.01% | 2646 |
|
|
2018
Q4 | $155K | Hold |
11,780
| – | – | ﹤0.01% | 2819 |
|
|
2018
Q3 | $433K | Hold |
11,780
| – | – | ﹤0.01% | 2480 |
|
|
2018
Q2 | $412K | Buy |
11,780
+2,700
| +30% | +$104K | ﹤0.01% | 2535 |
|
|
2018
Q1 | $422K | Hold |
9,080
| – | – | ﹤0.01% | 2424 |
|
|
2017
Q4 | $341K | Hold |
9,080
| – | – | ﹤0.01% | 2523 |
|
|
2017
Q3 | $484K | Sell |
9,080
-1,160
| -11% | -$68.9K | ﹤0.01% | 2367 |
|
|
2017
Q2 | $584K | Buy |
10,240
+1,800
| +21% | +$90.3K | ﹤0.01% | 2336 |
|
|
2017
Q1 | $454K | Buy |
8,440
+1,160
| +16% | +$65.5K | ﹤0.01% | 2425 |
|
|
2016
Q4 | $415K | Hold |
7,280
| – | – | ﹤0.01% | 2447 |
|
|
2016
Q3 | $452K | Hold |
7,280
| – | – | ﹤0.01% | 2364 |
|
|
2016
Q2 | $412K | Buy |
7,280
+5,760
| +379% | +$350K | ﹤0.01% | 2356 |
|
|
2016
Q1 | $97K | Hold |
1,520
| – | – | ﹤0.01% | 2935 |
|
|
2015
Q4 | $214K | Hold |
1,520
| – | – | ﹤0.01% | 2739 |
|
|
2015
Q3 | $147K | Buy |
1,520
+396
| +35% | +$47.2K | ﹤0.01% | 2920 |
|
|
2015
Q2 | $170K | Buy |
+1,124
| New | +$186K | ﹤0.01% | 2974 |
|
New York State Common Retirement Fund's KDNY Position: Q3 2023 in Review
New York State Common Retirement Fund sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 47,595 shares — an estimated $1.83M sold.
New York State Common Retirement Fund first reported a position in KDNY in Q2 2015 and held it in 33 quarters. The position peaked at $1.84M in Q4 2022. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- New York State Common Retirement Fund reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- New York State Common Retirement Fund sold 47,595 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.83M.
- New York State Common Retirement Fund first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 33 quarters.
- New York State Common Retirement Fund's Chinook Therapeutics, Inc. Common Stock position peaked at $1.84M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.